Securing retatrutide can be a hurdle for many. Currently, it is limited and necessitates a prescription from a medical provider. Receiving retatrutide typically involves participating in a clinical trial , though future broader release through traditional pharmaceutical channels is being considered – though a timeframe for this remains undefined